Page 4 - Clinical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gilead, Merck to team up on potential HIV combo treatment The two major pharmaceutical firms have agreed to jointly develop and commercialize treatment combinations of lenacapavir and islatravir in HIV patients. Gilead Sciences and Merck have entered into an agreement to co-develop and co-commercialize long-acting treatments in HIV. The intended solutions will combine Gilead’s investigational capsid inhibitor, lenacapavir, and Merck’s investigational nucleoside reverse transcriptase translocation inhibitor, islatravir, into a two-drug regimen with the potential...

The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90. IQVIA has announced its Orchestrated Customer Engagement (OCE) solution is now in use by 140 life-sciences companies located in 90 countries. The most recent to sign on, Laboratoires Thea, is an independent eye-care group in Europe. The company reports its clients are leveraging OCE to accelerate their global digital transformation, in order to lead to more impactful interactions with customers. Customers now inclu...

(ake1150sb/iStock via Getty Images Plus) A leader from the trial solutions provider discusses how the COVID-19 pandemic has accelerated the already growing interest in remote patient monitoring. Outsourcing-Pharma recently spoke with Stewart Whiting, chief technical officer of Current Health, about how the use of home health monitoring has evolved in the month leading up to the pandemic, its new Community by Current Health offering, and what the landscape might look like in the years ahead. OSP: Could you please share Current Health’s perspective on the industry�...

The DT Clinical Trial Digital Tracker Survey indicates many trial professionals often are hesitant to dive fully into digital technology integration. DT Consulting has released its inaugural Clinical Trial Digital Tracker Survey, designed to assess industry attitudes about digital adoption by global trial sites. According to the findings, many site professionals are reluctant to integrate digital tech into their process, citing factors like cost, complexity and selecting the appropriate tech for the job as the primary barriers. The survey was crafted to determine t...

Thermo Fisher Scientific expands DTP trial service offerings (ADragan/iStock via Getty Images Plus) The direct-to-patient service is designed to support trials and help to minimize trial length and costs, while boosting enrollment and participation rates. Thermo Fisher Scientific has expanded its direct-to-patient (DTP) service offerings. The range now includes clinical site-to-patient, pharmacy-to-patient, and depot-to-patient services, so that patients can receive medication and supplies directly to their homes. The DTP service builds on Thermo Fisher Scientific�...